Inverted U-Shaped relationship Between Systemic Immune-Inflammation Index and Pulmonary Function: A Large Population-Based Study in US Adults
Qian Yuan,Long-Wu Xiao,Yao Zhang,Long Li,Teng Xia,Qing Xu,Shi-Gui Xing,Liu-Shun Wang
DOI: https://doi.org/10.2147/copd.s471068
2024-09-03
International Journal of COPD
Abstract:Qian Yuan, &ast Long-Wu Xiao, &ast Yao Zhang, Long Li, Teng Xia, Qing Xu, Shi-Gui Xing, Liu-Shun Wang Department of Thoracic Surgery, Nan Jing Gaochun PEople's Hospital (The Gaochun Affiliated Hospital of Jiang Su University), Nanjing, Jiangsu, 210000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shi-Gui Xing; Liu-Shun Wang, Email ; Background: Systemic immune-inflammation index (SII) is a novel comprehensive inflammatory marker. Inflammation is associated with impaired lung function. We aimed to explore the possible relationship between SII and lung function to examine the potential of SII in predicting lung function decline. Methods: A cross-sectional survey was conducted using the data of the NHANES from 2007 to 2012. Multiple linear regression models were used to analyze the linear relationship between SII and pulmonary functions. Sensitivity analyses, subgroup analyses, and interaction tests were used to examine the robustness of this relationship across populations. Fitted smooth curves and threshold effect analysis were used to describe the nonlinear relationships. Results: A total of 10,125 patients were included in this study. After adjusting for all covariates, multiple linear regression model analysis showed that high Log2-SII level was significantly associated with decreased FVC(β, − 23.4061; 95% CI, − 42.2805- − 4.5317), FEV1(β, − 46.7730; 95% CI, − 63.3371- − 30.2089), FEV1%(β, − 0.7923; 95% CI, − 1.1635- − 0.4211), FEV1/FVC(β, − 0.6366; 95% CI, − 0.8328- − 0.4404) and PEF(β, − 121.4468; 95% CI,-164.1939- − 78.6998). The negative correlation between Log2-SII and pulmonary function indexes remained stable in trend test and stratified analysis. Inverted U-shaped relationships between Log2-SII and FVC, FEV1, FEV1%, and PEF were observed, while a negative linear correlation existed between FEV1/FVC and Log2-SII. The cutoff values of the nonlinear relationship between Log2-SII and FVC, FEV1, FEV1%, PEF were 8.3736, 8.0688, 8.3745, and 8.5255, respectively. When SII exceeded the critical value, the lung function decreased significantly. Conclusion: This study found a close correlation between SII and pulmonary function indicators. This study investigated the SII threshold when lung functions began to decline in the overall population. SII may become a promising serological indicator for predicting lung function decline. However, prospective studies were needed further to establish the causal relationship between these two factors. Keywords: NHANES, population-based study, systemic immune-inflammation index, pulmonary function Chronic respiratory diseases (CRD), including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer, are a group of diseases that affect the health of the lungs and trachea. 1,2 CRD is one of the leading causes of death worldwide and a major global public health problem. 3 Pulmonary function test is of great value for the diagnosis of respiratory diseases and the evaluation of therapeutic effect. International guidelines have forced vital capacity (FVC), and forced expiratory volume in 1 second (FEV1) as parameters, such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, asthma, and respiratory system disease diagnostic criteria. 4 Early and dynamic pulmonary function assessment is an effective means of early screening for chronic respiratory diseases, which helps to take targeted intervention measures before the progression of lung disease. 5 However, pulmonary function examination is not used as routine screening at all levels of medical and health care institutions worldwide, and most patients will undergo pulmonary function examination only when they have severe symptoms. At the same time, there are also some contraindications for pulmonary function testing, 6 such as myocardial infarction, massive hemoptysis, shock patients, etc. Pulmonary function testing plays an important role in the perioperative assessment, treatment, and prognosis of thoracic surgery patients. However, within 3 weeks after thoracic surgery, pulmonary function testing is also contraindicated. There is a lack of effective means of dynamic detection of lung function in patients with these conditions. 7 To sum up, finding a simple and effective biomarker to evaluate lung function is particularly important for early detection of lung function decline and timely prevention of further progression of impaired lung function. COPD is characterized by chronic bronchitis, chronic airway obstruction, airway remodeling, and emphysema, resulting in a progressive, irreversible decline in lung function. 8 A large number of studies<su -Abstract Truncated-
respiratory system